To evaluate the role of the mitochondrial peripheraltype benzodiazepine receptor (PBR) in steroidogenesis, we developed a molecular approach based on the disruption of the PBR gene, by homologous recombination, in the constitutive steroid producing R2C rat Leydig tumor cell line. Inactivation of one allele of the PBR gene resulted in the suppression of PBR mRNA and ligand binding expression. Immunoblot and electron microscopic immunogold labeling analyses confirmed the absence of the 18-kDa PBR protein in the selected clone. Although mitochondria from the PBR-negative cells contained high levels of the constitutively expressed 30-kDa steroidogenic activity regulator protein, these cells produced minimal amounts of steroids compared with normal cells (5%). Moreover, mitochondria from PBR-negative cells failed to produce pregnenolone when supplied with exogenous cholesterol. Addition of the hydrosoluble cholesterol derivative, 22R-hydroxycholesterol, increased steroid production by the PBRnegative R2C cells, indicating that the cholesterol transport mechanism was impaired. Stable transfection of the PBR-negative R2C Leydig cells with a vector containing the PBR cDNA resulted in the recovery of the steroidogenic function of the cells. These data demonstrate that PBR is an indispensable element of the steroidogenic machinery, where it mediates the delivery of the substrate cholesterol to the inner mitochondrial side chain cleavage cytochrome P-450.
tron transferring proteins, localized on inner mitochondrial membranes (1) (2) (3) (4) . The primary point of control in the acute stimulation of steroidogenesis, that occurs within minutes, by hormones is at the level of cholesterol transport, from intracellular sources to the inner mitochondrial membrane and the subsequent loading of cholesterol in the P-450scc active site (1) (2) (3) (4) . This hormone-dependent transport mechanism was shown to be mediated by cAMP and to be localized in the mitochondrion (1) (2) (3) (4) . Although a number of molecules have been proposed as potential candidates mediating this cholesterol transfer (3, 4) , no clear evidence has been presented on the identity of this mechanism. During the last decade, however, two cholesterol transport mechanisms have been identified and characterized as mediators of the acute stimulation of steroidogenesis by hormones, the PBR (5) and StAR (6) proteins.
PBR is an 18-kDa protein discovered as a class of binding sites for benzodiazepines distinct from the GABA A neurotransmitter receptor (5) . PBR are extremely abundant in steroidogenic cells (5) and found primarily on outer mitochondrial membranes (7) . PBR is a multimeric complex composed of the 18-kDa isoquinoline-binding protein and the 34-kDa poreforming voltage-dependent anion channel protein, preferentially located on the outer/inner mitochondrial membrane contact sites (8 -10) . Drug ligands of PBR, upon binding to the receptor, stimulate steroid synthesis in steroidogenic cells in vitro (11) (12) (13) (14) (15) . Likewise, in vivo studies showed that high affinity PBR ligands increase steroid plasma levels in hypophysectomized rats (16) . Moreover, drug-induced decrease in adrenal PBR expression resulted in reduced circulating glucocorticoid levels in rats (17) . Further in vitro studies on isolated mitochondria provided evidence that PBR ligands, drug ligands, or the endogenous PBR ligand, the polypeptide diazepam-binding inhibitor (5, 18) , stimulate pregnenolone formation by increasing the rate of cholesterol transfer from the outer to the inner mitochondrial membrane (19 -22) . We also showed that hormone-stimulated steroidogenesis involves, at least in part, the participation of PBR (23) . More recently, molecular modeling (24, 25) and in vitro reconstitution studies provided evidence that PBR may function as a mitochondrial cholesterol channel (18) . 2 StAR has been found only in gonadal and adrenal cells, where it is newly synthesized in response to trophic hormones and cAMP (26, 27) , as a cytoplasmic precursor protein of 37 kDa targeted to mitochondria (28, 29) . The precursor further undergoes cleavage to produce the 30-kDa mitochondrial StAR protein and its phosphorylated counterpart (6) . This protein processing is believed to occur at the level of the outer/inner mitochondrial membrane contact sites (6) . StAR synthesis parallels the maximal capacity of the cells to produce steroids in response to trophic hormones, and expression of StAR in the absence of hormonal stimulation resulted in a 3-fold increase in progesterone production by MA-10 Leydig cells (30, 31) . Both in vitro (30, 31) and in vivo (17) studies demonstrated that StAR is a hormone-regulated protein and mutations in StAR protein in humans is the cause of congenital lipoid adrenal hyperplasia, characterized by a deficiency in adrenal and gonadal steroid hormones (32) . Recent studies, however, demonstrated that StAR does not need to enter the mitochondria to stimulate steroidogenesis, suggesting that it functions by activating a mitochondrial receptor or transport mechanisms(s) (33) .
R2C cells, derived from rat Leydig tumors (34) , maintain their in vitro capacity to synthesize steroids constitutively in a hormone-independent manner (34, 35) . Thus, one can expect that constitutive steroidogenesis is driven by the unregulated expression of the hormonal mechanism controlling steroid synthesis or by an unknown separate mechanism. In 1994, we demonstrated that diazepam-binding inhibitor maintains constitutive steroidogenesis in R2C Leydig cells by binding to a mitochondrial higher affinity PBR which promotes continuous supply of cholesterol to the inner mitochondrial P-450scc (36) . This higher affinity site was induced by the addition of constitutive cytosolic proteins on the mitochondrial PBR (36) . In addition, Stocco and Chen (37) provided evidence that StAR was constitutively expressed in R2C cells. Thus, these cells provide the ideal system to examine the potential sequence of events mediating the mitochondrial cholesterol transport.
In this report, we describe the use of gene targeting in the R2C steroidogenic cells to introduce a null mutation into one allele of the PBR gene. Characterization of the wild type and the mutant cell lines, as well as the mutant cells transfected with the PBR cDNA, reveals that PBR is indispensable for cholesterol transport into mitochondria and steroid synthesis.
EXPERIMENTAL PROCEDURES

Materials-[
3 H]Ro5-4864 (specific activity, 86.9 Ci/mmol), [ 3 H]PK 11195 (specific activity, 86.9 Ci/mmol), [␣-32 P]dCTP (specific activity, 3000 Ci/mmol), [1,2-N-3 H]cholesterol (specific activity, 50 Ci/mmol), and [1,2,6,7-N-3 H]progesterone (specific activity, 94.1 Ci/mmol) were obtained from NEN Lif Science Products (Wilmington, DE). PK 11195 and Ro5-4864 were obtained from Research Biochemicals, Inc. (Natick, MA). Nitrocellulose (0.45 m) was from Hoeffer Scientific (San Francisco, CA). G418 and LipofectAMINE were purchased from Life Technologies (Gaithersburg, MD). Ganciclovir was a gift from Syntex (Palo Alto, CA), and trilostane was donated by Sterling-Winthrop (Surrey, United Kingdom). 22R-Hydroxycholesterol was purchased from Sigma. Restriction enzymes were from Stratagene (La Jolla, CA) and New England Biolabs (Beverly, MA). Cell culture supplies were purchased from Life Technologies, Inc. (Grand Island, NY) and cell culture plasticware was from Corning (Corning, NY). Electrophoresis reagents and materials were supplied from Bio-Rad. All other chemicals used were of analytical grade and were obtained from various commercial sources.
Construction of Vector for Homologous Recombination Experiments-On the basis of the known rat PBR gene sequence (38) , we designed two sets of primers that allowed us to amplify two fragments of the PBR gene from R2C cell genomic DNA by polymerase chain reaction (Fig. 1) . The first fragment (gPBR-I) spans the exon 2 (E2), intron 2 (I2), and the first 42 bp of exon 3 (E3). The second fragment (gPBR-II) spans 117 bp of exon 3 (E3), intron 3 (I3), and the first 270 bp of exon 4 (E4). gPBR-I and gPBR-II were sequenced, as we previously described (9) , to confirm that the nucleotide sequence of the rat R2C PBR gene is similar to that previously reported for the rat adrenal PBR gene (38) . These PBR genomic DNA fragments were cloned in the pBluescript-KS plasmid (Stratagene) and used to design the targeting construct.
The targeting vector was constructed by positioning the neo gene in between the two PBR genomic DNA fragments (Fig. 1) . Thus, the 1.15-kb HindIII/XhoI fragment containing the neo gene derived from PMC1-NeoPA (Stratagene) was ligated to the 3Ј-end of the gPBR-I. The 1.2-kb XhoI-KpnI gPBRII fragment was then inserted at the 3Ј XhoI site of the neo gene. This 3.2-kb construct was used for transfection in R2C cells as a control. A 3.0-kb HindIII/PvuI fragment of the HSV-tk gene was isolated from the pBS-tk plasmid (gift from Dr. G. Merlino, National Cancer Institute, National Institutes of Health, Bethesda), blunt-ended, and ligated into the 3Ј KpnI site of gPBR-II. At each step, the construction of the targeting vector was followed by nucleotide sequencing. The 6.2-kb construct was recovered by NotI digestion and used for transfection in R2C cells.
Cells and Homologous Recombination in R2C Cells-R2C cells from ATCC (Rockville, MD), derived from rat Leydig tumors (34) , were grown in modified Waymouth's MB752/1 medium containing 20 mM HEPES, 1.2 g/liter NaHCO 3 , and 10% horse serum, pH 7.4, as described previously (36) . Subconfluent monolayers of R2C cells, in 100-mm dishes, were transfected with 1-4 g/ml DNA using 8 -25 g/ml LipofectAMINE following the instructions of the manufacturer. After 2 days, the cells were treated with trypsin and plated onto 150-mm dishes. Selection was initiated with G418 (100 g/ml) 24 h after plating. After 6 days, ganciclovir (10 M) was added and clones resistant to both G418 and ganciclovir were isolated and characterized. Cells transfected with the 3.2-kb construct containing only the genomic PBR fragments with the neomycin gene were maintained only in the presence of G418 (100 g/ml). The concentrations of G418 and ganciclovir used were defined based on cytotoxic studies on R2C cells using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide cell proliferation assay (Boehringer Mannheim, Indianapolis, IN). Six days treatment with 100 g/ml G418 was toxic for the wild-type R2C cells. However, 10 days treatment with 10 M ganciclovir was not toxic for the R2C cells.
Expression of PBR in R2C PBR-negative Cells-The pZeoSV 2 vector (Invitrogen, Carlsbad, CA) which carries the Zeocin resistance gene was used to stably transfect the R3 PBR-negative R2C clone. Cell were selected using 100 g/ml Zeocin and examined for their ability to synthesize progesterone. The concentration of Zeocin used was defined based on cytotoxic studies performed as described above.
Radioligand Binding Assays-Radioligand binding assays were performed as described previously (11, 36) . In brief, cells were scrapped from culture flasks into phosphate-buffered saline, dispersed by trituration, and centrifuged at 1200 ϫ g for 5 min. The cells were resuspended in phosphate-buffered saline to a final concentration of 5-100 g of protein/100 l. Saturation binding studies were performed on 5 and 25 g of protein for the R2C cells, and 100 g of protein for the recombinant R2C clones, in a final volume of 300 l in the presence of the radioligand at the indicated concentrations. Nonspecific binding was determined in the presence of 6 M homologous nonradioactive ligand. After 3 h incubation at 4°C, the assays were stopped by filtration through Whatman GF/C filters (Clifton, NJ) and washing with 10 ml of phosphate-buffered saline. Bound radioactivity was determined by liquid scintillation counting. Total binding accounted for Ͻ10% of the radioligand introduced whereas specific binding was Ͼ85% of the total binding at all radioligand concentrations used. The dissociation constant (K d ) and the binding capacity were defined following Scatchard analysis of the specific binding using the LIGAND program (39) .
SDS-PAGE and Immunoblot Analysis-Mitochondria were isolated as we previously described (11, 19, 36) . Mitochondrial proteins were fractionated by one-dimensional SDS-PAGE (40) and electrotransferred onto nitrocellulose (36) . The nitrocellulose was subjected to immunoblot analysis using anti-PBR (1:800) or anti-StAR (1:800) antisera and goat anti-rabbit IgG alkaline phosphatase-conjugated secondary antibody followed by the substrate nitro blue tetrazolium/5-bromo-4-chloro-3-indolyl-phosphate for detection. Densitometric analysis of the immunoreactive protein bands was performed using the Sigmagel software (Jandel Scientific, San Rafael, CA). The production and characterization of the anti-PBR and anti-StAR antisera, against internal peptide sequences of the proteins have been previously described (17) .
Electron Microscopy Immunogold Analysis-The procedure of mitochondrial PBR labeling with a specific anti-PBR antiserum (1:200) followed by a goat anti-rabbit IgG conjugated to 8-nm gold particles (E-Y Inc., San Mateo, CA) has been described in detail elsewhere (10) . Samples were examined with a 1200 JEOL transmission electron microscope operated at 60 -80 kV.
RNA (Northern) Blot Analysis-Total cellular RNA was isolated by the acid guanidinium thiocyanate-phenol-chloroform extraction method using the RNAzol B reagent (Tel-Test Inc., Friendswood, TX). RNA electrophoresis, transfer, probe labeling, and membrane hybridization were performed as described previously (17) . The blots were then hybridized against the [ 32 P]cDNA probe for PBR (9) or cyclophilin labeled by the random priming technique. Screen enhanced autoradiography was performed by exposing Kodak X-Omat AR films to the blots at Ϫ80°C for 48 h.
Southern Blot Analysis-Genomic DNA from cells and rat adrenal tissue was isolated using the QIAamp tissue kit (Qiagen, Chatsworth, CA). 20 g of each DNA sample was digested with EcoRI restriction enzyme, electrophoresed on a 1% agarose gel, and transferred to derivatized nylon membranes (Nytran Plus, Schleicher & Schuell, Keene, NH) (41) . The Ϫ317 to ϩ36-bp fragment of the PBR gene (38) and the 1.1-kb XhoI/SalI fragment of neomycin gene from the PMC1-NeoPA vector were radiolabeled with [␣-32 P]dCTP using a random primers DNA labeling system (Life Technologies). The membrane was first prehybridized overnight at 68°C in 6 ϫ SSC, 0.5% SDS, and 100 g/ml denatured, fragmented salmon sperm DNA. After hybridization, the membrane was washed twice with 2 ϫ SSC, 0.5% SDS, for 10 min, once with 0.2 ϫ SSC, 0.5% SDS, for 30 -60 min at room temperature, and once with 0.2 ϫ SSC, 0.5% SDS, for 30 min at 60°C. Screen enhanced autoradiography was performed by exposing the blots to BioMax MS (Kodak, Rochester, NY) films at Ϫ80°C for 4 -48 h. Densitometric analysis of the spots was performed as described above.
Steroid Biosynthesis-To determine the steroidogenic capacity of the normal and selected recombinant clones, cells were plated in 22-mm wells and incubated for 2 h in a final volume of 1 ml of serum-free medium at 37°C. In some experiments the hydrosoluble analog of cholesterol, 22R-hydroxycholesterol, was added to the cells. Progesterone production, which represents the index of steroid biosynthesis by these cells (35, 36) was measured in cell media using an anti-progesterone antisera (Endocrine Sciences, Tarzana, CA) according to the conditions recommended by the manufacturer. Analysis of the radioimmunoassay data was performed using the "IBM-PC RIA Data Reduction" program (version 4.1) obtained from Jaffe and Associates (Silver Spring, MD).
Measurement of Cholesterol Transport in Mitochondria-To detect the transport and metabolism of exogenous cholesterol, mitochondria (1 mg/ml) were prepared and incubated as described by Leaver and Boyd (42) . In brief, mitochondria were incubated in a 10 mM potassium phosphate, pH 7.0, reaction buffer containing 250 mM sucrose, 5 mM MgCl 2 , 15 mM triethanolamine hydrochloride, 20 mM KCl, and 1 M trilostane, an inhibitor of pregnenolone metabolism (11, 43) . Mitochondria were preincubated for 5 min with [
3 H]cholesterol (1 Ci/100 nmol) and the cholesterol side chain cleavage reaction was initiated by addition of the electron donor isocitrate (15 mM) and NADP (0.5 mM). Samples were further incubated for 20 min at 37°C. The reaction was stopped with ethanol and the steroids were extracted with hexane. Pregnenolone was then separated by thin layer chromatography and radioactivity was quantified by liquid scintillation spectrometry (17) .
Protein Measurement-Protein was measured by the method of Bradford (44) using bovine serum albumin as a standard.
RESULTS AND DISCUSSION
Disruption of the PBR Locus by Gene
Targeting-To provide a definite answer on the role of PBR in steroidogenesis, we mutated the PBR allele in R2C Leydig cells using a replacement vector similar to those designed by Mansour and coworkers (45) . This type of vector has been successfully used to mutate a number of genes (45) (46) (47) (48) in different cell types, including steroidogenic cells (49) . The vector contains two selectable markers to allow for both positive and negative selection (45-49; Fig. 1) . A neo expression cassette, which confers resistance to the neomycin analog G418 and permits the selection (positive) of the cells which have integrated the recombinant replacement construct, was inserted between the two genomic sequences gPBR-I and gPBR-II described under "Experimental Procedures." Because of the need to distinguish the desired clones generated from homologous recombination from those where the common illegitimate recombination, random integration has occurred, a second marker, the herpes simplex thymidine kinase, was placed at the 3Ј-end-flanking region (negative selection) of the targeting construct. Thymidine kinase converts the purine analog ganciclovir into a toxic product. Integration of the targeting construct by homologous recombination leads to the loss of the thymidine kinase gene and resistance of the cells to ganciclovir. Thus, cells where random integration of the construct occurred will not grow in the presence of ganciclovir. Incorporation of the PBR recombinant construct in the right place in the genome can be studied by EcoRI digestion followed by hybridization with radiolabeled Ϫ317 to ϩ36-bp PBR gene fragment and 1.1-kb neo probes. The predicted sizes of the DNA fragments, based on the published rat genomic PBR (38) and the PMC1-NeoPA vector (Stratagene) sequences are: 10.5 kb for the PBR gene and 8.2 kb for the mutated allele. From the numerous transfections performed, five G418-and ganciclovir-resistant R2C cell clones were generated and successfully maintained for over a 1-year period in culture. These cells were named R2, R3, R12, R13, and R14. We chose the clone R3 to perform detailed studies on the role of PBR in constitutive steroidogenesis. Southern blot analysis of R2C rat Leydig tumor genomic DNA, cut with the restriction enzyme EcoRI generated the predicted fragment of 10.5 kb (Fig. 2) . This profile is similar to the previously published rat PBR gene structure (38) . Fig. 2 shows the autoradiogram from the Southern blot performed on the R3 G418-and ganciclovirresistant R2C clone. The results obtained demonstrated that the expected restriction fragments (10.5 and 8.2 kb) were labeled in the R3 mutants (Fig. 2) , indicating that the PBR gene was altered/interrupted. In addition, the fact that the R3 cell line had a PBR-mutated allele was further confirmed by the Southern blot performed with the neo probe. In this case, the absence of any hybridization with the normal cells and the labeling of a specific DNA fragment of predicted size (1.7 kb) in the recombinant cells, further suggests that the PBR gene was interrupted. Like many permanent cell lines, R2C cells are polyploid and more specifically tetraploid (50) . The Southern blot analysis demonstrated that only part of the PBR DNA was interrupted, since the bands found in normal cells were also present in the recombinant cell lines. Semiquantitative image analysis of the Southern blots demonstrated that indeed only one allele was mutated since only 25% of the radiolabeled PBR probe was associated with the gene fragment present only in the recombinant clones.
PBR Expression in Wild-type and Targeted R2C Cells-The G418-and ganciclovir-resistant targeted R2C R3 clone was screened for its ability to bind two high affinity PBR ligands, the isoquinoline carboxamide PK 11195 and the benzodiazepine Ro5-4864. The R3 clone showed a complete absence of any specific drug binding (Table I) . It should be noted that ligand binding in the targeted clone was assayed at much higher protein concentrations than the wild-type R2C cells (Table I) . PBR ligand binding by the G418-resistant targeted clone transfected with the 3.2-kb construct containing the genomic PBR fragments and the neomycin gene, was identical to the wild-type R2C cells. Thus, for the rest of our studies we used only the wild-type as the control cell type.
It was interesting to us, although not surprising, that inactivation of only one allele is associated with the abolishment of the gene function. Previous studies on 3T3-L1 cells demonstrated that inactivation of one of the eight copies of the insulin receptor gene resulted in a marked decrease in the number of plasma membrane insulin receptors (47) . In addition, disruption of only one copy of the mdr1b gene, encoding P-glycoprotein, in mouse adrenocortical cells resulted in increased drug accumulation, suggesting altered protein function (49) . It is possible that the multiple alleles of the inactivated gene are not transcribed at equal rates (47, 49) or that the targeted disruption of the PBR gene induced other changes resulting in the arrest or inhibition of the transcription and/or translation of the PBR gene.
Phase-contrast light microscopy revealed differences in the morphologic appearance of the targeted clone compared with the wild-type R2C cells (Fig. 3) . R3 cells in culture are shown in Fig. 3a . G418-resistant cells have similar morphology to the wild-type R2C cells (Fig. 3b) . The R3 mutants, however, expressed a different phenotype (Fig. 3c) , suggesting a multifunctional role of PBR. Indeed, in addition to the well examined function of PBR in steroidogenesis, PBR has been shown to be highly expressed in tumors and play a role in cell proliferation (5) . During these studies we noticed that the PBR mutant cells were slow to grow for the first 2 months with a doubling time in culture 2-3-fold higher than the wild-type R2C cells. 3 However, after 3 months in culture, the growth rates of the transformants recovered. At that time, the functional studies presented herein were performed. It is important to note that after 2 years in culture in some of the PBR-deficient cell lines PBR expression recovered. Interestingly, the recovery of PBR expression was accompanied by the recovery of steroid hormone synthesis by these cells. 3 The presence of the mitochondrial 18-kDa PBR protein in the wild-type and targeted R2C cells was then examined by immunoblot analysis (Fig. 4) . Mitochondria were prepared from the R3 mutant cell line, electrophoresed, transferred onto nitrocellulose, and blotted with an anti-PBR antiserum. In agreement with the binding experiments and our previous studies (36), the wild-type R2C mitochondria were found to express the 18-kDa isoquinoline-binding protein. In contrast, the R3 cells did not express the 18-kDa protein. This finding was further corroborated by transmission electron microscopy of mitochondria from the wild-type and the mutant cell line, where the 18-kDa PBR was immunolabeled and detected by a gold-labeled secondary antibody (Fig. 5) . To ascertain that the absence of PBR protein and ligand binding in R3 cells was due to the functional inactivation of the PBR gene, we performed PBR mRNA (Northern) analysis. Fig. 6 shows the presence of PBR mRNA in the wild-type R2C cells but not in the R3 cells, although both cells lines express the mRNA for the housekeeping gene cyclophilin.
StAR Expression in Wild-type and Targeted R2C CellsConsidering the proposed role of StAR in steroidogenesis (6) and the observation that it is constitutively expressed in the 3 H. Amri, H. Li, and V. Papadopoulos, unpublished data. R2C cells, where it may be responsible for sustaining the constitutive steroid production (37), we decided to examine whether StAR was present in the PBR-null mutant R2C cells. Immunoblot analysis of mitochondria prepared from the wildtype and the R3 mutant cell line indicated that both cells expressed equal amounts of StAR (Fig. 4) . As a control, we used the hormone-responsive MA-10 Leydig tumor cell line (11, 51) in which StAR is absent under basal conditions (31) . After 2 h upon addition of the trophic hormone choriogonadotropin, StAR appeared in the mitochondrial fraction, in agreement with previous findings (30, 31) . In contrast, a 2-h hormone treatment did not alter the levels of the 18-kDa PBR in the MA-10 mitochondria as we previously reported (52; Fig. 4) .
Steroid Synthesis by Wild-type and Targeted R2C Cells-R2C Leydig tumor cells produce steroids in a hormone-independent, constitutive manner (34 -37) . Progesterone is the major steroid produced by these cells. Kinetic studies showed a time-dependent production of progesterone production by the wild-type R2C cells with a maximum rate of 1.1 g/mg protein after 60 min (36) , similar to that found in hormone-stimulated MA-10 cells (11, 51) . Progesterone production by the PBR-null cells was dramatically reduced by 95% compared with the wild-type R2C cells levels (Fig. 7) . To assess whether this reduction of steroid synthesis was due to an impaired cholesterol transport mechanism, we incubated the cells with the hydrosoluble derivative of cholesterol, 22R-hydroxycholesterol. This hydroxylated cholesterol travels freely across the membranes to reach the inner mitochondrial P-450scc. Addition of 22R-hydroxycholesterol to R2C cells did not enhance the constitutive steroid synthesis, suggesting that the P-450scc reached its maximal activity using the endogenous cholesterol substrate. Addition of 22R-hydroxycholesterol resulted in the recovery, by 80%, of progesterone production by the PBR-null R2C cells (Fig. 7) .
Cholesterol Transport to Mitochondria in Wild-type and Targeted R2C Cells-We directly measured the ability of mitochondria isolated from wild-type and PBR-null R2C cells to transfer cholesterol to the P-450scc and synthesize pregnenolone. For this, we incubated the mitochondria with radiolabeled cholesterol, under the appropriate conditions, and we quantified the amount of radiolabeled pregnenolone formed. Fig. 8 shows that mitochondria from wild-type R2C cells transport cholesterol and form 0.8 nmol of pregnenolone per 20-min incubation time. In agreement with previous findings (36) , incubation of the mitochondria with the PBR benzodiazepine ligand Ro5-4864 stimulated cholesterol transport and pregnenolone formation. However, addition of the benzodiazepine clonazepam, which has no affinity for PBR, did not affect pregnenolone synthesis. In contrast, cholesterol transfer and pregnenolone formation were minimal (below 10% of control) in the R3 PBR mutants Fig. 9 shows that expression of PBR in R3 mutant cells rescued steroidogenesis, demonstrating the permissive role of PBR in the steroidogenic function. CONCLUSION We have used the constitutive steroid-producing R2C Leydig cell to construct a PBR-null steroidogenic cell line using a method of gene inactivation based on targeted homologous recombination using selectable marker genes. In this PBR mutant cell line, steroidogenesis ceased due to the arrest of cholesterol transport across the outer mitochondrial membrane to the inner mitochondrial P-450scc. However, introduction of PBR in the PBR-negative R2C cells rescued steroidogenesis. These results are in agreement with our recent in vivo studies where a drug-induced decrease in adrenal PBR expression resulted in reduced circulating glucocorticoid levels in rats (17) and targeted mutagenesis of PBR showed its lethal effect on mouse embryo survival (18) . Thus, these data provide unequivocal evidence on the determining role of PBR in cholesterol transport and steroid synthesis.
Because PBR is a mitochondrial protein (5, 7), PBR-null cells express high levels of StAR (present study), in vivo reduction of adrenal PBR expression and corticosterone synthesis occurred despite the presence of high levels of StAR (17) , and StAR does not need to enter the mitochondria to stimulate pregnenolone formation (33), we propose that PBR acts after StAR and that PBR may control or mediate the effect of StAR on mitochondrial steroid synthesis. In addition, the observations that (i) a cytosolic protein is required for the appearance of a higher affinity PBR coupled to constitutive (36) and hormone-induced (52) steroid synthesis, (ii) PBR is coupled to voltage-dependent anion channel (9), a protein located on the outer/inner mitochondrial membrane contact sites, and (iii) the StAR precursor is targeted to mitochondria where it may be cleaved at the contact sites to enter the mitochondria (6) , suggest that the coordinated interaction of PBR and StAR may be the key to the induction and maintenance of steroid synthesis. 
